论文信息 - Phase II study of yttrium-90-ibritumomab tiuxetan in patients with relapsed or refractory mantle cell lymphoma. - 字舞流文

Phase II study of yttrium-90-ibritumomab tiuxetan in patients with relapsed or refractory mantle cell lymphoma.

Michael L. Wang | Maria A. Rodriguez | Y. Oki | P. Mclaughlin | A. Younes | Yuan Ji | E. Loyer | S. Neelapu | F. Hagemeister | B. Pro | J. Romaguera | B. Samuels | F. Samaniego | A. Copeland | M. Rodriguez